Furthermore, we observed that the co‐overexpression of both CRC TFs led to even stronger activation of the enhancer activity of E2 compared to overexpression of either one alone, providing further evidence for the collaboration of SOX9 and TCF7L2 in activating SOX9’s SE. The gene discussed is TCF7L2; the disease is colorectal carcinoma.